Bayer CropScience Posts 21% PAT Growth for FY26, Recommends ₹150 Dividend

AGRICULTURE
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Bayer CropScience Posts 21% PAT Growth for FY26, Recommends ₹150 Dividend

Bayer CropScience reported a strong FY26 with revenue up 4% to ₹5,675 crore and Profit After Tax (PAT) surging 21% to ₹689 crore. The company recommended a total dividend of ₹150 per share.

Detailed Coverage

Bayer CropScience Reports Strong FY26 Performance, Dividend Payout

Revenue ₹5,675 crore; Profit After Tax ₹689 crore.

Reader Takeaway: Double-digit profit growth driven by product innovation and market leadership, amidst global headwinds.

What just happened

Bayer CropScience announced its financial results for the fiscal year 2025-26. The company reported a 4% increase in revenue from operations, reaching ₹5,675 crore. Profit After Tax (PAT) saw a significant jump of 21%, closing at ₹689 crore. The Board of Directors has recommended a final dividend of ₹60 per share, adding to the interim dividend of ₹90 paid earlier, making a total payout of ₹150 per share for the fiscal year.

Why this matters

This strong financial performance indicates robust operational efficiency and market demand for Bayer CropScience's products. The substantial dividend payout signals confidence from the management in the company's profitability and cash flow generation capabilities, which is a positive for shareholders.

The backstory

Bayer CropScience is a key player in India's agriculture sector, focusing on crop protection and seeds. The company has consistently worked on launching new products and strengthening its market position, particularly in the corn seed segment with its DEKALB brand, which it has led for four consecutive years.

What changes now

Shareholders will receive a total dividend of ₹150 per share for FY26. The company is also seeking shareholder approval for material related party transactions with its ultimate holding company, Bayer AG, for up to ₹3,500 crore for FY28, covering goods and services on an arm's length basis.

Risks to watch

The company faces risks from macroeconomic headwinds, including geopolitical tensions and supply chain disruptions. Potential weather volatility, such as El Niño conditions, could also impact agricultural cycles and demand for agri-inputs.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

Bayer CropScience's revenue for FY 2025-26 stood at ₹5,675 crore, a 4% increase from ₹5,473 crore in FY 2024-25. PAT grew by 21% to ₹689 crore in FY 2025-26, compared to ₹568 crore in the previous year.

What to track next

Investors will monitor the upcoming 68th Annual General Meeting on August 19, 2026, and the approval of related party transactions. The successful integration of the seven new products launched across insecticide, herbicide, and fungicide categories will also be crucial.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.